A software deal worth up to $250,000 has a client group that includes current and former NFL athletes as ambassadors.
Medical Care Technologies Inc. (MDCE) announced a multi-year software agreement worth up to $250,000, marking its first external software revenue. The deal involves custom AI software and includes current and former NFL athletes as ambassadors. CEO Marshall Perkins highlighted this as a milestone in monetizing the company's AI technology. MDCE also continues development on other platforms, including Melanoma Scan Beta and StrainScan Pro.
How this was made
The 30-second read
Why it matters
The first external software deal signals a strategic shift toward enterprise licensing, potentially diversifying revenue streams.
Market read
A modest, first‑time software contract for MDCE; unlikely to cause significant price movement but indicates a new revenue avenue.
What to watch
Future pipeline of software deals could accelerate revenue if the company secures larger contracts.
Background
Medical Care Technologies (MDCE) is a diversified AI‑driven health and wellness technology company that previously generated revenue only from its mobile app.
Ticker impact
Medical Care Technologies announced its first external software agreement, a multi-year deal valued up to $250,000.
limited upside as the deal is small; market may view it as a positive milestone but unlikely to move price materially.
The announcement is a primary disclosure but the monetary size is modest, so any price reaction is expected to be muted.
Market effects
Shows emerging revenue streams for AI‑focused health tech firms, but impact on the broader sector is minimal.
Limited to the company's niche market; no broader regional effect.
Low relevance to global markets.
Counterpoint
Investors may view the small contract as insufficient to sustain growth expectations.
Key entities
- companyMedical Care Technologies Inc.
Issuer of the software agreement.
- personMarshall Perkins
CEO of Medical Care Technologies, quoted in the release.
